Second Edition Pharmaceutical Cannabis Report 2021: Featuring Almirall, Bayer and Novartis Among Others – ResearchAndMarkets.com
Cannabis Law Report
DECEMBER 23, 2021
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.
Let's personalize your content